Cargando…
Inhibitors of riboflavin biosynthetic pathway enzymes as potential antibacterial drugs
Multiple drug resistance is the main obstacle in the treatment of bacterial diseases. Resistance against antibiotics demands the exploration of new antimicrobial drug targets. A variety of in silico and genetic approaches show that the enzymes of the riboflavin biosynthetic pathway are crucial for t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366380/ https://www.ncbi.nlm.nih.gov/pubmed/37496776 http://dx.doi.org/10.3389/fmolb.2023.1228763 |